一贝共享资源下载
VaxArray 产品资源
产品彩页
文献
肺炎球菌疫苗
Byrne-Nash, R.T., et al. VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines. 2018. NPJ Vaccines. 3:43; doi:10.1038/s41541-018-0080-6
Kuck L.R., et al. VaxArray assessment of influenza split vaccine potency and stability. 2017. Vaccine. 15(35) 1918-1925. doi:10.1016/j.vaccine.2017.02.028
Fox, A., et al. Opposing effects of prior infection versus prior vaccination on vaccine immunogenicity against influenza A(H3N2) viruses. 2022. Viruses. 14(3):470. doi:10.3390/v14030470
Byrne-Nash, R.T., et al. A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines. 2019. NPJ Vaccines. 4:3; doi:10.1038/s41541-019-0099-3
Centi, C., et al. VaxArray seasonal influenza assessment of adjuvant-containing vaccine formulation. Poster presented at World Vaccines Conference 2017.
Byrne-Nash, R.T., et al. VaxArray assessment of influenza vaccine potency and stability. Poster presented 2016.
流感疫苗
Byrne-Nash, R.T., et al. VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines. 2018. NPJ Vaccines. 3:43; doi:10.1038/s41541-018-0080-6
Kuck L.R., et al. VaxArray assessment of influenza split vaccine potency and stability. 2017. Vaccine. 15(35) 1918-1925. doi:10.1016/j.vaccine.2017.02.028
Fox, A., et al. Opposing effects of prior infection versus prior vaccination on vaccine immunogenicity against influenza A(H3N2) viruses. 2022. Viruses. 14(3):470. doi:10.3390/v14030470
Byrne-Nash, R.T., et al. A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines. 2019. NPJ Vaccines. 4:3; doi:10.1038/s41541-019-0099-3
Centi, C., et al. VaxArray seasonal influenza assessment of adjuvant-containing vaccine formulation. Poster presented at World Vaccines Conference 2017.
Byrne-Nash, R.T., et al. VaxArray assessment of influenza vaccine potency and stability. Poster presented 2016.
脊髓灰质炎疫苗